The Evaluation of the Clinical Effectiveness and Safety of Biologic Therapies in Psoriasis-Real-World Evidence up to 64 Weeks of Therapy.

Bimzelx (bimekizumab-bkzx) - UCB

Humira (adalimumab) - AbbVie

Tremfya (guselkumab) - J&J

http://www.ncbi.nlm.nih.gov/pubmed/42646636

Iwona Flisiak; Julia Nowowiejska-Purpurowicz; Patrycja Lemiesz; Tomasz W Kaminski

Aug 27, 2026